MedPath
HSA Approval

AZITHROMYCIN MEVON POWDER FOR SOLUTION FOR INFUSION 500 mg/vial

SIN14490P

AZITHROMYCIN MEVON POWDER FOR SOLUTION FOR INFUSION 500 mg/vial

AZITHROMYCIN MEVON POWDER FOR SOLUTION FOR INFUSION 500 mg/vial

January 20, 2014

NOVEM PHARMA PRIVATE LIMITED

NOVEM PHARMA PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM PHARMA PRIVATE LIMITED
Licence HolderNOVEM PHARMA PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

J01FA10

azithromycin

Manufacturer Information

NOVEM PHARMA PRIVATE LIMITED

Laboratório Reig Jofré, S.A.

Active Ingredients

Azithromycin dihydrate 524.03mg eq. to Azithromycin

500.00mg

Azithromycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AZITHROMYCIN MEVON POWDER FOR SOLUTION FOR INFUSION 500 mg/vial - HSA Approval | MedPath